Prevalence and impact of fibrinolytic dysregulation in patients with acute coronary syndromes

OBJECTIVE: Dual antiplatelet therapy can reduce coronary thrombosis and improve the prognosis in patients with acute coronary syndrome (ACS). However, there was limited prognostic information about fibrinolytic dysregulation in patients with ACS. This study is aimed to evaluated the prevalence and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Huaibin, Fan, Xin, Wu, Zhihao, Lie, Zhenbang, Li, Daqiang, Su, Shaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141118/
https://www.ncbi.nlm.nih.gov/pubmed/34022898
http://dx.doi.org/10.1186/s12959-021-00288-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141118/
https://www.ncbi.nlm.nih.gov/pubmed/34022898
http://dx.doi.org/10.1186/s12959-021-00288-5

Ejemplares similares